Anna Iervolino

5PUBLICATIONS
21CO-AUTHORS
Genetically modified horticulture plantsGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Microbial geneticsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2025
Innovations in Targeting the V2 Receptor.

Francesco Trepiccione, Anna Iervolino

|Nov 01, 2023
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI.

Francesco Trepiccione, Anna Iervolino, Mariavittoria D'Acierno

|Jul 12, 2022
Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b.

Mariavittoria D'Acierno, Roberta Resaz, Anna Iervolino

|Apr 10, 2022
Single nephron glomerular filtration rate measured by linescan multiphoton microscopy compared to conventional micropuncture.

Vincenzo Costanzo, Luciano D'Apolito, Donato Sardella

|Mar 17, 2021
Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus.

Federica Petrillo, Anna Iervolino, Tiziana Angrisano

Pageof 1